[SRNE] YoY Quarter Result on 30-Sep-2018 [#Q3]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
09-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- 35.93%
YoY- -239.37%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
Revenue 12,062 11,753 5,778 4,105 121,910 2,243 1,103 48.93%
PBT -119,773 -86,398 -74,002 -50,380 94,953 14,031 33,244 -
Tax 386 145 -221 -826 57,480 -195 35,323 -52.86%
NP -119,803 -84,023 -64,415 -47,328 33,959 14,373 -939 124.20%
Tax Rate - - - - -60.54% 1.39% -106.25% -
Total Cost 131,865 95,776 70,193 51,433 87,951 -12,130 2,042 100.17%
Ratio Analysis
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
NP Margin -993.23 -714.91 -1,114.83 -1,152.94 27.86 640.79 -85.13 50.54%
Per Share
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
EPS -0.40 -0.33 -0.49 -0.40 0.44 0.22 -0.03 53.92%
EPS Diluted -0.40 -0.33 -0.46 -0.40 0.44 0.22 -0.03 53.92%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.